Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Our services

Contacting us

If you have already been referred to the department and seen one of the team within the last year, then you can contact the department directly. If not, you need to see your GP and talk to them about whether a referral to the department is appropriate.

Clinic appointments

If you want to change or check an appointment, please phone the Contact Centre: 01904 726400

Physiotherapy and Occupational Therapy appointments

If you want to change or check an appointment, please phone the Therapy Department: 01904 725389 or725390

Podiatry appointments

If you want to change or check an appointment, please phone 01904 724222 or email Podiatry.Appointments@HDFT.NHS.UK

Support and advice about your condition or treatment

If you need support and advice about your condition and treatment, contact the Rheumatology Advice Line: 01904 721854

You should leave a message and we will get back to you as soon as we can. Don't forget to leave your name, telephone number and hospital number or date of birth.

Or you could email us: rheumemailadvice@york.nhs.uk

Click here for more information about the Rheumatology Advice Service.

Looking down a long bright hospital corridor with treatment rooms on the left and windows on the right. At the bottom of the corridor is one member of staff in a blue nursing uniform

Our Hospitals

Two female receptionists on the phone at a desk smiling

Feedback

Chinese Poland

View all languages >

Visiting update

To protect our patients, staff, visitors and the community, we are again restricting visitors to all our hospitals sites so please read our latest guidance for full details before coming to our hospitals.

The decision to restrict visitors during this time has been very difficult and made only after careful consideration as we witness wider social restrictions to prevent the spread of COVID-19 in light of the highly transmissible OMICRON variant.  The guidance will be reviewed regularly.